These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21536612)

  • 21. Is the incidence of acute mountain sickness (AMS) at medium altitude in the Austrian Alps influenced by the height of home residence of the alpinist?
    Röggla G; Wagner A; Röggla M
    Acta Med Hung; 1992-1993; 49(3-4):233-8. PubMed ID: 1345461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
    Moraga FA; Flores A; Serra J; Esnaola C; Barriento C
    Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arterial oxygen saturation for prediction of acute mountain sickness.
    Roach RC; Greene ER; Schoene RB; Hackett PH
    Aviat Space Environ Med; 1998 Dec; 69(12):1182-5. PubMed ID: 9856544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute mountain sickness in the Southern Alps of New Zealand.
    Murdoch DR; Curry C
    N Z Med J; 1998 May; 111(1065):168-9. PubMed ID: 9612485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are the laboratory and field conditions observations of acute mountain sickness related?
    Savourey G; Guinet A; Besnard Y; Garcia N; Hanniquet A; Bittel J
    Aviat Space Environ Med; 1997 Oct; 68(10):895-9. PubMed ID: 9327114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute altitude sickness in children.
    Neumann K
    J Travel Med; 1999 Sep; 6(3):210. PubMed ID: 10576945
    [No Abstract]   [Full Text] [Related]  

  • 27. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT).
    Gertsch JH; Lipman GS; Holck PS; Merritt A; Mulcahy A; Fisher RS; Basnyat B; Allison E; Hanzelka K; Hazan A; Meyers Z; Odegaard J; Pook B; Thompson M; Slomovic B; Wahlberg H; Wilshaw V; Weiss EA; Zafren K
    Wilderness Environ Med; 2010 Sep; 21(3):236-43. PubMed ID: 20832701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of 3,184 cases with acute mountain sickness complicated by multiple organ dysfunction syndrome].
    Zhou QQ; Liu FY; Zheng BH; Gao YQ; Li SZ; Wang HB; Zhang SF
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):36-40. PubMed ID: 17207363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternations of heart rate variability at lower altitude in the predication of trekkers with acute mountain sickness at high altitude.
    Huang HH; Tseng CY; Fan JS; Yen DH; Kao WF; Chang SC; Kuo TB; Huang CI; Lee CH
    Clin J Sport Med; 2010 Jan; 20(1):58-63. PubMed ID: 20051736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute mountain sickness at 3500 and 4250 m. A study of symptom, incidence and severity].
    Vargas M; Osorio J; Jiménez D; Moraga F; Sepúlveda M; Del Solar J; Hudson C; Cortés G; León A
    Rev Med Chil; 2001 Feb; 129(2):166-72. PubMed ID: 11351468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct measurement of intracranial pressure at high altitude and correlation of ventricular size with acute mountain sickness: Brian Cummins' results from the 1985 Kishtwar expedition.
    Wilson MH; Milledge J
    Neurosurgery; 2008 Nov; 63(5):970-4; discussion 974-5. PubMed ID: 19005388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute mountain sickness--the "poison of the pass".
    Bailey DM
    Br J Sports Med; 1999 Dec; 33(6):376. PubMed ID: 10597843
    [No Abstract]   [Full Text] [Related]  

  • 33. Symptoms of infection and altitude illness among hikers in the Mount Everest region of Nepal.
    Murdoch DR
    Aviat Space Environ Med; 1995 Feb; 66(2):148-51. PubMed ID: 7726779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features of patients with severe altitude illness in Nepal.
    Leshem E; Pandey P; Shlim DR; Hiramatsu K; Sidi Y; Schwartz E
    J Travel Med; 2008; 15(5):315-22. PubMed ID: 19006504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The diagnosis, treatment and prevention of acute and subacute mountain sickness].
    Golub VI; Luft VM
    Voen Med Zh; 1990 Mar; (3):52-5. PubMed ID: 2375090
    [No Abstract]   [Full Text] [Related]  

  • 36. Preexisting cardiovascular diseases among high-altitude mountaineers in the alps.
    Faulhaber M; Gatterer H; Burtscher M
    J Travel Med; 2011; 18(5):355-7. PubMed ID: 21896101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Application of quantitative proteomics in the study of acute mountain sickness].
    Tu B; Wei X; Shang H; Liu Z; Wang Y; Gao Y
    Sheng Wu Gong Cheng Xue Bao; 2023 Sep; 39(9):3594-3604. PubMed ID: 37805840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological modeling of acute mountain sickness (AMS). A prospective data collection standard.
    Vann RD; Pollock NW; Pieper CF; Murdoch DR; Muza SR; Natoli MJ; Wang LY
    Adv Exp Med Biol; 2003; 543():355-8. PubMed ID: 14713134
    [No Abstract]   [Full Text] [Related]  

  • 39. Incidence of acute mountain sickness at intermediate altitudes.
    Houston CS
    JAMA; 1989 Jun 23-30; 261(24):3551-2. PubMed ID: 2724500
    [No Abstract]   [Full Text] [Related]  

  • 40. Predicting susceptibility to acute mountain sickness.
    Miller MR; Pincock AC; Wright AD
    Lancet; 1983 Jul; 2(8342):164. PubMed ID: 6135008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.